FLT3 and acute myeloid leukemia: Out of 3290 newly diagnosed AML patients included in the DATAML registry between 2000 and 2017, 1453 did not have a recorded status for FLT3 mutation and 364 were not selected to receive intensive chemotherapy as a first-line treatment.